Nicholas P. Tobin - School of Cancer, Enabling Sciences and Technology, University of Manchester

基本信息

浏览量：51

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 110 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Decoding Cell Cycle Phase Variations in Cancer Hallmarks Across Breast Cancer Subgroups

Miguel Castresana Aguirre,Alexios Matikas, Linda Lindstrom,Nicholas P. Tobin

biorxiv（2025）

引用0浏览0引用

Cellular and Secretome Profiling Uncover Immunological Biomarkers in the Prognosis of Renal Cell Carcinoma Patients

Le Tong,Veronika Kremer,Shi Yong Neo,Christina Seitz,Nicholas P Tobin,Barbara Seliger, Ulrika Harmenberg, Eugenia Colón, Ann-Helén Scherman Plogell, Lisa L Liu,Andreas Lundqvist

Oncoimmunologyno. 1 (2025): 2481109-2481109

引用0浏览0WOS引用

Myogenic IGFBP5 Levels in Rhabdomyosarcoma Are Nourished by Mesenchymal Stromal Cells and Regulate Growth Arrest and Apoptosis

Yue Zhang, Karim Katkhada, Liu Zhen Meng, Binbin Zhao, Shanlin Tong, Wiem Chaabane, Aditi Kallai,Nicholas P. Tobin,Arne Östman,Alessandro Mega,Monika Ehnman

Cell Communication and Signalingno. 1 (2025): 1-18

引用0浏览0WOS引用

267P the Tumour Microenvironment Influences Long-Term Tamoxifen Treatment Response in Breast Cancer Patients

P. Camargo Romera, M. Rios Romero, O. Danielsson, H. Akhtar Dar,L.S. Lindström,N.P. Tobin

Annals of Oncology (2024): S327

引用0浏览0引用

Clinically Relevant Gene Signatures Provide Independent Prognostic Information in Older Breast Cancer Patients

Miguel Castresana-Aguirre,Annelie Johansson,Alexios Matikas,Theodoros Foukakis,Linda S. Lindström,Nicholas P. Tobin

Breast Cancer Researchno. 1 (2024)

引用1浏览0WOS引用

300P Gene Expression Landscape of the Long-Term Tamoxifen Resistance in Premenopausal ER+ Breast Cancer Patients in the STO-5 Controlled Randomized Clinical Trial with >20-Year Follow-Up

J. Tutzauer, J.K.J. De Vos,A. Nordenskjöld,B.A. Nordenskjöld,T. Fornander, G. Pérez Tenorio,O. Stål,N.P. Tobin,L.S. Lindström

Annals of Oncology（2024）

引用0浏览0引用

409P Biological Tumor Traits Predicting Late Recurrence in Premenopausal Breast Cancer Patients: Insights from the STO-5 Trial with 20-Year Follow-Up

J.K.J. De Vos, J. Tutzauer,A. Nordenskjöld,B.A. Nordenskjöld,T. Fornander, G. Pérez Tenorio,O. Stål,N.P. Tobin,L.S. Lindström

Annals of Oncology (2024): S390-S390

引用0浏览0引用

Differential Long-Term Tamoxifen Therapy Benefit by Menopausal Status in Breast Cancer Patients: Secondary Analysis of a Controlled Randomized Clinical Trial

Annelie Johansson,Huma Dar,Anna Nordenskjold,Gizeh Perez-Tenorio,Nicholas P. Tobin,Christina Yau, Christopher C. Benz,Laura J. Esserman,Laura J. van 't Veer,Bo Nordenskjold,Olle Stal,Tommy Fornander,Linda S. Lindstrom

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2024)

引用0浏览0WOS引用

316P Differential Long-Term Benefit of 2-Year Adjuvant Tamoxifen Therapy for Luminal-Type Breast Cancer: Insights from a 20-Year Follow-Up Analysis of the STO Trials

M. Rios Romero, O. Danielsson,T. Fornander,A. Nordenskjöld, G. Pérez Tenorio,N.P. Tobin,B.A. Nordenskjöld,O. Stål,L. Esserman, L.J. Van't Veer,L.S. Lindström

Annals of Oncology (2024): S346

引用0浏览0引用

A Phenotypic Screening Approach to Target P60amotl2-Expressing Invasive Cancer Cells

Pedro Fonseca,Weiyingqi Cui,Nona Struyf,Le Tong,Ayushi Chaurasiya, Felipe Casagrande,Honglei Zhao, Dinura Fernando,Xinsong Chen,Nicholas P. Tobin,Brinton Seashore-Ludlow,Andreas Lundqvist,Johan Hartman,Anita Göndör,Päivi Östling,Lars Holmgren

Journal of Experimental & Clinical Cancer Research（2024）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn